Form 4: Colgate-Palmolive Director Hundmejean Receives Stock Grant and Option Award
SEC Form 4 Filing
Director Martina Hundmejean acquired 1,905 shares of common stock and an option to purchase 2,201 shares of common stock from Colgate-Palmolive on May 13, 2024.
Summary
- On May 13, 2024, Martina Hundmejean, a director of Colgate-Palmolive, acquired 1,905 shares of common stock as an annual director stock grant.
- These shares were credited to a stock unit account under the company's incentive compensation plan.
- Hundmejean also received an annual director stock option grant for 2,201 shares with an exercise price of $94.46.
- The options become exercisable in equal annual installments over three years, starting May 13, 2025.
- Following these transactions, Hundmejean directly owns 10,525 shares of common stock and options for 2,201 shares.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive as it reflects standard compensation practices for a director, aligning interests with shareholders.
Positives
- The director's stock and option grants align her interests with those of the shareholders.
- The vesting schedule of the options encourages long-term commitment.
Future Outlook
The director's holdings will increase over the next three years as the stock options vest.
Industry Context
Stock grants and options are common forms of executive compensation in publicly traded companies, aligning management's interests with shareholder value.
Comparison to Industry Standards
- Director compensation packages, including stock grants and options, are standard practice among large publicly traded companies like Colgate-Palmolive.
- Companies such as Procter & Gamble (PG) and Unilever (UL) also utilize similar compensation strategies to incentivize their directors and executives.
- The specific amounts and vesting schedules can vary based on company size, performance, and industry benchmarks.
Stakeholder Impact
- The stock and option grants align the director's interests with those of the shareholders, potentially driving decisions that increase shareholder value.
Key Dates
| Date | Description |
|---|---|
| 05/13/2024 | Date of stock grant and option award |
| 05/13/2025 | First vesting date for stock options |
| 05/13/2032 | Expiration date of stock options |
| 05/15/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.